finanzen.net
12.07.2019 20:05
Bewerten
(0)

Mindshare Medical announces CE Mark for RevealAI-Lung: The first AI-based solution for radiology diagnostics cleared in Europe

DRUCKEN

SEATTLE, July 12, 2019 /PRNewswire/ -- Mindshare Medical announced today that its RevealAI-Lung product has been cleared for sale in Europe (CE Mark) for use with CT scans of the lung.

The product, a Computer Assisted Diagnostic (CADx) software for lung cancer diagnosis, is the first diagnostic platform to gain regulatory clearance in its class. RevealAI-Lung can significantly improve clinicians' diagnostic efficacy and optimize recommendations for follow-up, while integrating seamlessly with existing Picture Archiving and Communication Systems (PACS).

Mindshare has demonstrated the potential for reducing both false-positives and time to diagnosis, which may reduce patient exposure to unnecessary imaging procedures and biopsy in some cases, while also providing the opportunity to treat lung cancer at an earlier stage.

Lung cancer is the leading cause of death among men and women worldwide with 376,000 deaths in Europe in 2017, which represents 20% of all cancer deaths.  It also accounts for the loss of 3.2 million disability-adjusted life-years annually.

Taking into account Europe's 5-year net survival rate of 18%, the ability to intercept and treat a malignant nodule even a few months earlier could yield significant benefit to patients. In addition to these clinical advantages, when considering the financial burden to the healthcare system, reducing the unnecessary procedures from false-positives yields substantial cost-savings. Mindshare's RevealAI can play a key role in the adoption of value-based health care and increase the implementation of lung cancer screening programs throughout Europe.

"We at Mindshare are very pleased to bring RevealAI to the European market as the first cleared CADx product. Our partners in the UK and across the continent have recognized the value that Mindshare can bring for managing lung nodules. From radiology to thoracic surgery, there are broad implications, and we're excited about delivering this benefit to help patients and help healthcare systems deliver care."
Michael Calhoun, PhD. CEO, Mindshare Medical

Mindshare Medical develops revolutionary, evidence-based clinical decision support technologies that provide personalized diagnostics and guidance for more effective follow-up procedures and treatments. This precision medicine radiomics approach is intended to dramatically optimize patient outcomes and reduce the financial burden for health care organizations. Mindshare's solutions are designed to fit within existing clinical workflows - delivering impactful insights at the clinician's fingertips.

Cision View original content:http://www.prnewswire.com/news-releases/mindshare-medical-announces-ce-mark-for-revealai-lung-the-first-ai-based-solution-for-radiology-diagnostics-cleared-in-europe-300884219.html

SOURCE Mindshare Medical

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX beendet Handel höher -- US-Börsen mit leichtem Plus -- ams mit OSRAM-Gegenofferte -- Bayer-Strafe deutlich gesenkt -- Citigroup übertrifft Erwartungen -- Carl Zeiss Meditec, EVOTEC im Fokus

Moody's: BASF-Rating droht Herabstufung. Trump droht dem mit mauem Wachstum kämpfenden China mit neuen Zöllen. Milliardendeal zwischen Broadcom und Symantec angeblich geplatzt. OMV mit Millioneninvestition in Deutschland. Rheinmetall ergattert Großauftrag. Bitcoin rauscht unter 10.000 US-Dollar. Airbus-Aktie auf Rekordhoch.

Die 5 beliebtesten Top-Rankings

Promis
Diese Sternchen haben ihren eigenen Aktien-Index
Diese Aktien hat Warren Buffett im Depot
Die Änderungen unter den Top-Positionen
Die erfolgreichsten Kinofilme der letzten 25 Jahre
Welche Titel knackten die Milliardenmarke an den Kinokassen?
Das verdienen Aufsichtsratschefs in DAX-Konzernen
Deutlich unter Vorstandsgehältern
Apps & Social Media: Die wertvollsten Marken der Welt
Welche Marke macht das Rennen?
mehr Top Rankings

Umfrage

Wo sehen Sie den DAX Ende 2019?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
Deutsche Bank AG514000
Daimler AG710000
NEL ASAA0B733
Amazon906866
BayerBAY001
CommerzbankCBK100
BASFBASF11
Microsoft Corp.870747
Infineon AG623100
TeslaA1CX3T
Airbus SE (ex EADS)938914
Apple Inc.865985
EVOTEC SE566480
Deutsche Telekom AG555750